| | 特定对象调研 分析师会议 √ □ | | --- | --- | | 投资者关系 | 媒体采访 业绩说明会 □ □ | | | 新闻发布会 路演活动 □ □ | | 活动类别 | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位 | 国信证券组织的投资者 | | 时间 | 2026 年 1 月 11 日 | | 地点 | 进门财经电话会议 | | 上市公司接 | 副总裁、首席信息官 吴维严 | | | 副总裁、董事会秘书 陶钧 | | 待人员姓名 | 医策科技 王晓梅 CEO | | | 公司管理层对投资者提问的回复情况如下： | | | 1．AI 对医疗行业是否带来结构性重塑？ | | | 答：将推动医疗健康应用快速发展，尤其在基层医疗与健康 | | | 管理场景。但复杂病症与循证医学领域的 AI 应用仍需高质量多 | | | 模态数据支撑。患者端将受益于全生命周期健康管理；在医生端， | | | AI 主要作为辅助工具，助力经验知识平民化。迪安通过"临床科 | | 投资者关系 | 研+基层赋能"闭环推动产品落地。 | | 活动主要内 | 【风险提示：目前公司的 AI ...

A股今日（1月13日）全线回调，沪指午后跌近1%，创业板指一度跌超2%，全A成交近3.7万亿元，再度刷 新历史纪录，且已连续三个交易日突破3万亿元。港股方面，恒生指数强势上扬涨近1%，恒生科技指数盘 中一度翻绿，尾盘翻红。 具体来看，沪指早盘窄幅震荡，尾盘加速跳水，创业板指、科创50指数大幅下探。截至收盘，沪指跌0.64%报 4138.76点，深证成指跌1.37%，创业板指跌1.96%，科创50指数跌2.8%，沪深北三市合计成交约3.7万亿元，较 此前一日增加约540亿元。 全A超3700股飘绿，近期强势的商业航天概念大幅回调，此前4个交易日翻倍的邵阳液压大跌超13%，中国卫 通、航天发展、江顺科技等均跌停；半导体板块亦下挫，长光华芯、赛微微电等跌超10%；保险、银行板块逆 市拉升，新华保险涨超4%续创历史新高，中国人寿涨逾3%；AI医疗概念活跃，诺思格、泓博医药等涨停；创 新药概念拉升，荣昌生物、普蕊斯等涨停。值得注意的是，大牛股锋龙股份已连续斩获13个涨停板，鲁信创 投13日收获11板，引力传媒（603598）7日斩获6板。 医药股拉升 AI医疗概念盘中强势拉升，截至收盘，诺思格、泓博医药、博济医药等涨停 ...

Market Overview - A-shares opened high but closed lower, with the Shanghai Composite Index down 0.64%, Shenzhen Component Index down 1.37%, and ChiNext Index down 1.96%. The total trading volume in the Shanghai and Shenzhen markets was approximately 3.70 trillion yuan, showing a slight increase compared to the previous trading day. More than 3,700 stocks declined [1] Industry Insights - The commercial aerospace sector saw significant activity, leading to a market pullback. However, this correction is considered normal after continuous gains, and the spring market trend is expected to continue. Investors are advised to focus on technology growth and related sectors such as commercial aerospace, AI applications, and new energy, while also considering cash flow/dividend assets to mitigate market volatility [1] - The medical services, precious metals, and GEO concept stocks were among the top gainers today, while commercial aerospace, semiconductors, and chemical fiber industries experienced the largest declines [1] Pharmaceutical Sector Highlights - The pharmaceutical sector led the market gains due to several key developments: 1. Rongchang Bio signed an exclusive licensing agreement with AbbVie for RC148, with a total transaction value of 5.6 billion USD, highlighting the significant market potential of the PD-1/VEGF dual antibody track [2] 2. WuXi AppTec, a leading CXO, announced its 2025 performance forecast, expecting annual revenue of 45.456 billion yuan, a year-on-year increase of 15.84%, exceeding expectations [2] 3. Tempus AI reported better-than-expected earnings, with diagnostic business revenue of 955 million USD, a year-on-year growth of 111%, indicating ongoing global advancements in AI medical technology [2] - The pharmaceutical sector's global competitiveness continues to strengthen, with ongoing international expansion and commercial profitability [2] Power Grid Sector Developments - The domestic power grid performed relatively well in the afternoon, driven by the demand for renewable energy consumption from large-scale wind and solar projects. The vast territory of China necessitates long-distance transportation, which is expected to further stimulate demand for UHV (Ultra High Voltage) construction. During the 14th Five-Year Plan period, UHV DC is expected to maintain an annual approval pace of 3 to 4 lines, while UHV AC is anticipated to approve an average of 2 large projects annually [2] - In North America, explosive growth in AIDC (Artificial Intelligence Data Center) is creating new electricity demand, and China's complete power grid industry chain, efficient delivery, and rich overseas experience position it as a key supplier to fill this gap [2]

主线热点 2026年1月12日凌晨，谷歌宣布与沃尔玛、塔吉特、Wayfair、Etsy等全球头部零售商达成合作，并正式 开源面向电商领域的AI智能体协议通用商业协议。隔夜美股中概股集体走强，阿里巴巴大涨10%。此前 受到马斯克宣布在7天内开源X最新一代推荐算法提振的AI应用端延续强势，GEO概念天龙集团、引力 传媒、利欧股份、三维通信实现连板晋级，不过20厘米中军蓝色光标放量巨震，仍受到其进入重点监控 名单影响，拖累弹性方向人气股流金科技、易点天下、值得买等纷纷炸板回落。整个应用端连板高度和 连板股家数的显著减少，对于弹性方向的赚钱效应压制明显。不过随着今日分歧的率先释放，若市场短 线情绪能够企稳，不排除20厘米方向部分个股存在反包修复可能。 英伟达宣布，将在未来五年内与礼来共同投资10亿美元建立人工智能药物实验室。AI医疗、AI制药概 念受此消息刺激双双爆发，泓博医药、美年健康一字涨停，带动思创医惠、诺思格、博济医药、贝瑞基 因等多股涨停。综合多券商研报观点，AI制药核心价值在于大幅提升药物早研效率，候选药物从靶点 发现到临床前候选药物确认时间有望显著缩短三分之二以上，因此一些主营聚焦于临床前试验的CXO ...

Core Viewpoint - The news highlights the strong performance of WuXi AppTec, with significant revenue and profit growth projections for 2025, driven by its integrated CRDMO business model and increasing demand for its services [3][4]. Group 1: Company Performance - WuXi AppTec expects to achieve approximately 454.56 billion yuan in revenue for 2025, representing a year-on-year growth of about 15.84%, with a 21.4% increase in revenue from continuing operations [3]. - The adjusted net profit attributable to shareholders is projected to be around 149.57 billion yuan, reflecting a year-on-year increase of approximately 41.33% [3]. - The company has revised its revenue guidance upwards, with total revenue expectations adjusted from 425-435 billion yuan to 435-440 billion yuan for 2025 [3]. Group 2: Market Trends - The Hang Seng Biotechnology ETF (513280) saw a 1.57% increase, with trading volume exceeding 1.4 billion yuan, indicating a significant uptick in market interest [1]. - WuXi AppTec's stock rose over 8%, outperforming many peers in the biotechnology sector, which also saw positive movements [4]. Group 3: Industry Insights - The AI healthcare application sector is rapidly advancing, with significant policy support and market demand driving commercialization [6]. - AI in drug development is expected to enhance early-stage research efficiency, significantly reducing the time required for drug candidate identification [6][7]. - The integration of AI in healthcare is becoming increasingly prevalent, with tools like ChatGPT Health facilitating better health information management for users [8][9].

Group 1: AI Applications - Elon Musk announced the open-sourcing of the X recommendation algorithm, with the GEO (Generative Engine Optimization) concept gaining traction, focusing on content optimization strategies for large models [5] - DeepSeek is expected to release its latest flagship AI model in February, with Zhuoyi Information launching the SnapDevelop professional version, which includes an AI programming assistant supporting major AI models [6] - Zhuoyi Information's stock saw a maximum increase of 31.88% over two days, reflecting strong market interest in AI programming tools [6] Group 2: AI Marketing - JD.com launched an AI marketing agent named "Jingxiaotong," indicating a significant transformation in the marketing industry driven by digitalization and intelligence [9] - Institutions predict that the AIGC advertising market will grow tenfold to 150 billion yuan by 2030, with a global market size exceeding 100 billion USD and China's market reaching 24 billion yuan [9][10] - Yidian Tianxia, a company with over ten years of partnership with Google, has seen its stock rise by 71.44% over three days, benefiting from its early positioning in GEO business [10] Group 3: AI Healthcare - NVIDIA and Eli Lilly plan to invest $1 billion over five years to establish an AI drug laboratory, aiming to accelerate medical discoveries [13] - OpenAI's release of ChatGPT Health targets the trillion-dollar AI healthcare market, with institutions identifying healthcare as a key application area for AI [13][15] - The Chinese AI healthcare market is projected to grow from 8.8 billion yuan in 2023 to 315.7 billion yuan by 2033, with a compound annual growth rate of 43.1% [21] Group 4: Commercial Aerospace - The successful suborbital flight test of the Li Hong No. 1 remote sensing vehicle by China Aerospace Science and Technology Corporation marks a significant achievement in commercial aerospace [23] - Jieli Suojun, a traditional rigging leader, reported a 397.1% year-on-year increase in net profit for the first three quarters of 2025, driven by new business expansions and structural optimization [24] - The company has transitioned from providing general rigging to becoming a key subsystem in rocket solutions, indicating strong market positioning in the commercial aerospace sector [24] Group 5: Photovoltaic and Space Technology - Junda Co. is focusing on photovoltaic batteries, with over half of its business coming from overseas, and is strategically investing in satellite battery companies to enter the space photovoltaic market [26] - The company's products have achieved over 33% efficiency, and it has completed principle verification in flexible perovskite aerospace applications [26] - Junda's stock has risen by 40.51% over five days, reflecting investor confidence in its growth potential in the space technology sector [26]

今日（1.13），港药再度走强，同类费率最低档的恒生生物科技ETF（513280）收涨1.57%，全天成交额超1.4亿元，环比放量超87%！ | 分时 多日 1分 5分 15分 30分 60分 = 综合屏 F9 前复权 超级叠加 画线 工具 ② ② > | | 恒生生物科技ETF ① | | 513280 | | --- | --- | --- | --- | --- | | 513280.SH[恒生生物科技ETF] 2025/09/03 收1.372 幅1.55%(0.021) 开1.380 高1.384 低1.353 均1.37座 | | | | | | MA5 1.3261 MA10 1.3221 MA20 1.3051 MA60 1.1821 MA120 1.0261 MA250 0.8541 | (66日)▼ a | 1.372 | | +0.021 +1.55% | | | 1.40 | SSE CNY 13:43:14 交易中 | | T+0 / QF | | | | 净值走势 | | 汇添富恒生生物科技ETF | | | | 委比 | -34.40% 委差 | -9381 | | | | 卖五 ...

东吴证券指出，从经济基本面看，今年留给美联储降息的窗口不多，宽财政对经济的脉冲效应还在路 上。一季度美联储不降息的话，港股反弹节奏就更要看分子端情况。港股整体配置维持哑铃策略，建议 控制配置仓位，等待更多消息释放。价值红利为底仓，进攻方向继续关注市场共识，AI科技、有色、 创新药。 港股今日冲高回落，恒指早盘一度冲破两万七，恒科指数午后则一度转跌。截止收盘，恒生指数涨 0.9%或239.99点，报26848.47点，全日成交额为3151.92亿港元；恒生国企指数涨0.71%，报9285.41点； 恒生科技指数涨0.11%，报5869.79点。 蓝筹股表现 药明康德（603259）(02359)领涨蓝筹。截至收盘，涨8.3%，报120港元，成交额14.22亿港元，贡献恒指 6.85点。1月12日晚，药明康德公布，公司全年预计实现营业收入454.56亿元，同比增长15.84%；其 中，持续经营业务收入同比增长约21.40%。预计经调整归母净利润149.57亿元，同比增长约41.33%；归 属于公司股东的净利润191.51亿元，同比增长约 102.65%。 其他蓝筹股方面，药明生物(02269)涨5.85%，报39 ...

责任编辑：钟离 1月13日，百川智能创始人兼CEO王小川表示，公司预计将于2027年启动IPO上市。谈及近期备受关注 的AI大模型企业上市，王小川表示，"他们主要还是踩在通用模型技术红利和政策支持的基础上，但目 前他们的市值和商业化能力并不匹配，但AI医疗今天也是大模型竞争中的一个范式，虽然它的成熟会 晚一点，在后面我们的路径，肯定也是奔着上市去的。 财经频道更多独家策划、专家专栏，免费查阅>> ...

上天天基金APP搜索777注册即可领500元券包，优选基金10元起投！限量发放！先到先得！ 1月13日，三大指数集体调整。截至收盘，沪指跌0.64%，深成指跌1.37%，创业板指跌1.96%。 板块来看，AI应用逆势上涨、AI医疗概念反复活跃、电网设备概念午后走强。下跌方面，商业航天、 可控核聚变等板块跌幅居前。 全市场超3700只个股下跌。沪深两市成交额3.65万亿元，较上一个交易日放量496亿。 连续上攻的A股市场，今天"终于"迎来调整。 浮盈较多的持筹者，也得到了比较有确定性的卖点； 当然，也不是所有人都对此感到开心—— 数据显示，沪指终结了此前的17连阳，颇具标志性；全A平均股价等指标，也都录得2026年日线级别 的"首阴 " 。与此同时， 全市场成交额达到36988亿元，比昨天又放量了一些。 | F9 不复权 超级叠加 画线 工具 ② | | 全A平均股价 | | 8841719 | | | --- | --- | --- | --- | --- | --- | | 2025/07/18-2026/01/13(120日)▼ | | | | -0.50 -1.71% | | | | | 15:00:0 ...